Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junmin Li

Showing results (301-310 of 312) with videos related to

Pageof 32
Sort By:
British Journal of Haematology|February 12, 2024
Cardiac effects of deferasirox in transfusion-dependent patients with myelodysplastic syndromes: TELESTO studyMatteo Sarocchi, Junmin Li, Xiao Li, et al.
The Lancet. Haematology|April 7, 2023
Sovleplenib (HMPL-523), a novel Syk inhibitor, for patients with primary immune thrombocytopenia in China: a randomised, double-blind, placebo-controlled, phase 1b/2 studyXiaofan Liu, Hu Zhou, Yu Hu, et al.
Cancer Medicine|March 14, 2018
Ibrutinib versus rituximab in relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma: a randomized, open-label phase 3 studyXiaojun Huang, Lugui Qiu, Jie Jin, et al.
American Journal of Hematology|July 20, 2023
Safety and efficacy of jaktinib (a novel JAK inhibitor) in patients with myelofibrosis who are intolerant to ruxolitinib: A single-arm, open-label, phase 2, multicenter studyYi Zhang, Hu Zhou, Minghui Duan, et al.
Medicine|August 16, 2021
Real-world assessment of the effectiveness of posaconazole for the prophylaxis and treatment of invasive fungal infections in hematological patients: A retrospective observational studyXiaochen Chen, Jianxiang Wang, Sanbin Wang, et al.
Science Advances|October 13, 2021
Widespread vulnerability of flowering plant seed production to pollinator declinesJames G Rodger, Joanne M Bennett, Mialy Razanajatovo, et al.
Cancer Research|February 28, 2024
Mutant U2AF1-Induced Mis-Splicing of mRNA Translation Genes Confers Resistance to Chemotherapy in Acute Myeloid LeukemiaPeng Jin, Xiaoling Wang, Qiqi Jin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2023
The Oral PI3Kδ Inhibitor Linperlisib for the Treatment of Relapsed and/or Refractory Follicular Lymphoma: A Phase II, Single-Arm, Open-Label Clinical TrialTingyu Wang, Xiuhua Sun, Lihua Qiu, et al.
Frontiers in Endocrinology|February 23, 2026
Effect of acupuncture pretreatment on clinical pregnancy rate in women with diminished ovarian reserve undergoing IVF-ET: study protocol for a multicenter randomized controlled trialXin Liu, Chenchen Su, Junmin Li, et al.
Leukemia & Lymphoma|October 16, 2014
Efficacy and safety of ruxolitinib in Asian patients with myelofibrosisChul Won Jung, Lee-Yung Shih, Zhijian Xiao, et al.
Pageof 32

Showing results (301-310 of 312) with videos related to

Sort By:
Pageof 32
British Journal of Haematology|February 12, 2024
Cardiac effects of deferasirox in transfusion-dependent patients with myelodysplastic syndromes: TELESTO studyMatteo Sarocchi, Junmin Li, Xiao Li, et al.
The Lancet. Haematology|April 7, 2023
Sovleplenib (HMPL-523), a novel Syk inhibitor, for patients with primary immune thrombocytopenia in China: a randomised, double-blind, placebo-controlled, phase 1b/2 studyXiaofan Liu, Hu Zhou, Yu Hu, et al.
Cancer Medicine|March 14, 2018
Ibrutinib versus rituximab in relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma: a randomized, open-label phase 3 studyXiaojun Huang, Lugui Qiu, Jie Jin, et al.
American Journal of Hematology|July 20, 2023
Safety and efficacy of jaktinib (a novel JAK inhibitor) in patients with myelofibrosis who are intolerant to ruxolitinib: A single-arm, open-label, phase 2, multicenter studyYi Zhang, Hu Zhou, Minghui Duan, et al.
Medicine|August 16, 2021
Real-world assessment of the effectiveness of posaconazole for the prophylaxis and treatment of invasive fungal infections in hematological patients: A retrospective observational studyXiaochen Chen, Jianxiang Wang, Sanbin Wang, et al.
Science Advances|October 13, 2021
Widespread vulnerability of flowering plant seed production to pollinator declinesJames G Rodger, Joanne M Bennett, Mialy Razanajatovo, et al.
Cancer Research|February 28, 2024
Mutant U2AF1-Induced Mis-Splicing of mRNA Translation Genes Confers Resistance to Chemotherapy in Acute Myeloid LeukemiaPeng Jin, Xiaoling Wang, Qiqi Jin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2023
The Oral PI3Kδ Inhibitor Linperlisib for the Treatment of Relapsed and/or Refractory Follicular Lymphoma: A Phase II, Single-Arm, Open-Label Clinical TrialTingyu Wang, Xiuhua Sun, Lihua Qiu, et al.
Frontiers in Endocrinology|February 23, 2026
Effect of acupuncture pretreatment on clinical pregnancy rate in women with diminished ovarian reserve undergoing IVF-ET: study protocol for a multicenter randomized controlled trialXin Liu, Chenchen Su, Junmin Li, et al.
Leukemia & Lymphoma|October 16, 2014
Efficacy and safety of ruxolitinib in Asian patients with myelofibrosisChul Won Jung, Lee-Yung Shih, Zhijian Xiao, et al.
Pageof 32